Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 10/20 | 0.43 |
| ▸ | HRH1 | P35367 | 12/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.42 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL739066 | 0.92 | HRH1 (0.42) | KCNH2HRH1CYP2D6CHRM1PROKR1 | |
| SCHEMBL739065 | 0.92 | HRH1 (0.42) | KCNH2HRH1CYP2D6CHRM1PROKR1 | |
| SCHEMBL762888 | 0.92 | KCNH2 (0.45) | KCNH2HRH1CYP2D6CHRM1PROKR1 | |
| SCHEMBL762716 | 0.91 | KCNH2 (0.43) | KCNH2HRH1CYP2D6CHRM1PROKR1 | |
| SCHEMBL762638 | 0.91 | KCNH2 (0.44) | KCNH2HRH1CYP2D6CHRM1PROKR1 | |
| SCHEMBL763506 | 0.90 | KCNH2 (0.44) | KCNH2HRH1CYP2D6CHRM1PROKR1 | |
| SCHEMBL762728 | 0.90 | KCNH2 (0.43) | KCNH2HRH1CYP2D6CHRM1PROKR1 | |
| SCHEMBL762721 | 0.90 | KCNH2 (0.46) | KCNH2HRH1CYP2D6CHRM1PROKR1 | |
| SCHEMBL762619 | 0.89 | KCNH2 (0.43) | KCNH2HRH1CYP2D6CHRM1PROKR1 | |
| SCHEMBL762895 | 0.89 | KCNH2 (0.43) | KCNH2HRH1CYP2D6CHRM1PROKR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138168-B1 | Renin inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-20 | — | — | US | disclosed |